Adicet Bio, Inc. Common Stock
ACET Real Time Price USDRecent trades of ACET by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in ACET holdings by institutional investors
Quarterly net insider trading by ACET's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Former government officials who have lobbied for ACET
13 former government officials from 7 congressional offices at 3 lobbying firms have lobbied for ACET, most recently Oct 18, 2024.
-
Chris Maneval House New Deputy Chief of Staff, House Republican Whip Emmer; Chief of Staff, Rep. Emmer; Legislative Director, Rep. Emmer; Senior Leg Assistant, Rep. Forbes; Leg Assistant, Rep. Forbes; Leg Aide, Rep. Forbes; Staff Assistant, Rep. Forbes -
Stephen Newton Senate New Deputy Legislative Director, Sen. Romney; Senior Policy Advisor, Sen. Romney; Legislative Assistant, Sen. Romney; Legislative Assistant, Sen. Kennedy; Research Assistant, Senate Committee on Small Business and Entrepreneurship -
Drew Cole Senate New Intern for Senator Don Nickels (R-OK)
-
Jennifer Read House New Deputy Chief Counsel, House Financial Services Committee; Senior Counsel, House Financial Services Committee; Counsel, House Financial Services Committee; Presidential Management Fellow, U.S. Department of Housing and Urban Affairs
-
Sean Richardson Senate New Chief of Staff, Sen. Amy Klobuchar (2006-2007); Chief of Staff, Rep. Patrick Kennedy (2002-2007); Deputy Staff Dir., Senate Democratic Conference Committee (1999-2002) -
Andrew Mckechnie Congress New Health Policy Adviser, Sen. Finance Cmte. (2009-2010); Legislative Assistant, Sen. Norm Coleman (2007-2008); Legislative Assistant, Rep. Jim Ramstad (2005-2007); Staff Assistant, Rep. Jim Ramstad (2005)
-
Bryant Hall Senate New Staff Director, Sen. Veterans Affairs Committee (2003-2004); Legislative Director, Sen. Bob Graham (1999-2003)
-
John Twomey House New Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)
ACET Estimated quarterly lobbying spending
ACET Revenue by Segment or Geography
New ACET patent grants
-
Patent Title: Methods for selective expansion of γδ t-cell populations and compositions thereof Apr. 12, 2022
-
Patent Title: Engineered γδ t-cells Oct. 05, 2021
Federal grants, loans, and purchases
Estimated quarterly amount awarded to ACET from public contracts
Recent insights relating to ACET
Recent picks made for ACET stock on CNBC
ETFs with the largest estimated holdings in ACET
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ACET stock a Buy, Sell, or Hold?
- What is the price target for $ACET stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ACET stock?
- Who owns the most shares of $ACET stock?
- What funds own $ACET stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACET Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
- Address Boston, MA
- Market Cap 77.4 million
- Employees 102
- Industrial Classification Pharmaceutical Preparations
Adicet Bio, Inc. Common Stock (ACET) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for Adicet Bio, Inc. Common Stock (ACET).
Quiver Premium charts ACET's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at ACET, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|